Company / Accounts Receivable
Xtant Medical Holdings, Inc. Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$17.8M
FY2025
5-year range
$7.2M / $20.7M
FY2021-FY2025
Trend
-14.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable has fluctuated over the past 10 years, ranging from $7M in FY2020 to $21M in FY2024.
Based on SEC 10-K filings.
$18M in FY2025 with a 5-year CAGR of +20.9%.
Declined from $21M to $18M over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +17.9%
- 5-Year CAGR
- +20.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +20.9%, indicating consistent growth.
- In FY2025, accounts receivable decreased 14.1% year-over-year.
- Peak accounts receivable was recorded in FY2024.
- Lowest accounts receivable in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.8M | -14.1% |
| FY2024 | $20.7M | +0.0% |
| FY2023 | $20.7M | +91.0% |
| FY2022 | $10.9M | +51.7% |
| FY2021 | $7.2M | +4.0% |
| FY2020 | $6.9M | -32.0% |
| FY2019 | $10.1M | +1.3% |
| FY2018 | $10.0M | -21.4% |
| FY2017 | $12.7M | -33.1% |
| FY2016 | $19.0M | +23.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026